Hepatitis B virus mutants and fulminant hepatitis B: Fitness plus phenotype
2001; Lippincott Williams & Wilkins; Volume: 34; Issue: 2 Linguagem: Inglês
10.1053/jhep.2001.26764
ISSN1527-3350
AutoresAngeline Bartholomeusz, S. Locarnini,
Tópico(s)Liver Disease Diagnosis and Treatment
ResumoHepatologyVolume 34, Issue 2 p. 432-435 EditorialFree Access Hepatitis B virus mutants and fulminant hepatitis B: Fitness plus phenotype Angeline Bartholomeusz Ph.D., Angeline Bartholomeusz Ph.D. From Research & Molecular Development, VIDRL, North Melbourne, Victoria, Australia.Search for more papers by this authorStephen Locarnini M.D., Corresponding Author Stephen Locarnini M.D. From Research & Molecular Development, VIDRL, North Melbourne, Victoria, Australia.Research & Molecular Development, VIDRL, 10 Wreckyn Street, North Melbourne, Victoria, 3051, Australia===Search for more papers by this author Angeline Bartholomeusz Ph.D., Angeline Bartholomeusz Ph.D. From Research & Molecular Development, VIDRL, North Melbourne, Victoria, Australia.Search for more papers by this authorStephen Locarnini M.D., Corresponding Author Stephen Locarnini M.D. From Research & Molecular Development, VIDRL, North Melbourne, Victoria, Australia.Research & Molecular Development, VIDRL, 10 Wreckyn Street, North Melbourne, Victoria, 3051, Australia===Search for more papers by this author First published: 30 December 2003 https://doi.org/10.1053/jhep.2001.26764Citations: 45AboutPDF ToolsRequest permissionExport citationAdd to favoritesTrack citation ShareShare Give accessShare full text accessShare full-text accessPlease review our Terms and Conditions of Use and check box below to share full-text version of article.I have read and accept the Wiley Online Library Terms and Conditions of UseShareable LinkUse the link below to share a full-text version of this article with your friends and colleagues. Learn more.Copy URL Share a linkShare onEmailFacebookTwitterLinkedInRedditWechat References 1 Summers J, Mason WS. Replication of the genome of a hepatitis B–like virus by reverse transcription of an RNA intermediate. Cell 1982; 29: 403–415.MEDLINE 2 Bock CT, Schranz P, Schroder CH, Zentgraf H. Hepatitis B virus genome is organized into nucleosomes in the nucleus of the infected cell. Virus Genes 1994; 8: 215–229.MEDLINE 3 Okamoto H, Imai M, Kametani M, Nakamura T, Mayumi M. Genomic heterogeneity of hepatitis B virus in a 54-year-old woman who contracted the infection through materno-fetal transmission. Jpn J Exp Med 1987; 57: 231–236.MEDLINE 4 Sterneck M, Gunther S, Gerlach J, Naoumov NV, Santantonio T, Fischer L, Rogiers X, et al. Hepatitis B virus sequence changes evolving in liver transplant recipients with fulminant hepatitis. J Hepatol 1997; 26: 754–764.MEDLINE 5 Gunther S, Fischer L, Pult I, Sterneck M, Will H. Naturally occurring variants of hepatitis B virus. Adv Virus Res 1999; 52: 25–137.MEDLINE 6 Chisari F, Ferrari C. Hepatitis B virus immunopathogenesis. Ann Rev Immunol 1995; 13: 29–60. 7 Angus P, Richards M, Bowden S, Ireton J, Sinclair R, Jones B, Locarnini S. Combination chemotherapy controls severe post-liver transplant recurrence of hepatitis B virus infection. J Gastroenterol Hepatol 1993; 8: 353–357.MEDLINE 8 Sterneck M, Kalinina T, Gunther S, Fischer L, Santantonio T, Greten H, Will H. Functional analysis of HBV genomes from patients with fulminant hepatitis. Hepatology 1998; 28: 1390–1397.MEDLINE 9 Locarnini SA, Civitico GM, Newbold JE. Hepatitis B: new approaches for antiviral chemotherapy. Antivir Chem Chemother 1996; 7: 1–12. 10 Summers J, Smith PM, Horwich AL. Hepadnavirus envelope proteins regulate covalently closed circular DNA amplification. J Virol 1990; 64: 2819–2824.MEDLINE 11 Lenhoff RJ, Summers J. Construction of avian hepadnavirus variants with enhanced replication and cytopathicity in primary hepatocytes. J Virol 1994; 68: 5706–5713.MEDLINE 12 Lenhoff RJ, Luscombe CA, Summers J. Competition in vivo between a cytopathic variant and a wild-type duck hepatitis B virus. Virology 1998; 251: 85–95.MEDLINE 13 Persing DH, Varmus HE, Ganem D. The preS1 protein of hepatitis B virus is acylated at its amino terminus with myristic acid. J Virol 1987; 61: 1672–1677.MEDLINE 14 Kuroki K, Russnak R, Ganem D. Novel N-terminal amino acid sequence required for retention of a hepatitis B virus glycoprotein in the endoplasmic reticulum. Mol Cell Biol 1989; 9: 4459–4466.MEDLINE 15 Mehta A, Lu X, Block TM, Blumberg BS, Dwek RA. Hepatitis B virus (HBV) envelope glycoproteins vary drastically in their sensitivity to glycan processing: evidence that alteration of a single N-linked glycosylation site can regulate HBV secretion. Proc Natl Acad Sci U S A 1997; 94: 1822–1827.MEDLINE 16 Hadziyannis S, Raimondo G, Papaioannou C, Anastassakos C, Wong D, Sninsky J, Shafritz D. Expression of pre-S gene-encoded proteins in liver and serum during chronic hepatitis B virus infection in comparison to other markers of active virus replication. J Hepatol 1987; 5: 253–259.MEDLINE 17 Trautwein C, Schrem H, Tillmann HL, Kubicka S, Walker D, Boker KH, Maschek HJ, et al. Hepatitis B virus mutations in the pre-S genome before and after liver transplantation. Hepatology 1996; 24: 482–488.MEDLINE 18 Bock CT, Tillmann HL, Maschek HJ, Manns MP, Trautwein C. A preS mutation isolated from a patient with chronic hepatitis B infection leads to virus retention and misassembly. Gastroenterology 1997; 113: 1976–1982.MEDLINE 19 Carman WF, Fagan EA, Hadziyannis S, Karayiannis P, Tassopoulos NC, Williams R, Thomas HC. Association of a precore genomic variant of hepatitis B virus with fulminant hepatitis. Hepatology 1991; 14: 219–222.MEDLINE 20 Ogata N, Miller RH, Ishak KG, Purcell RH. The complete nucleotide sequence of a pre-core mutant of hepatitis B virus implicated in fulminant hepatitis and its biological characterization in chimpanzees. Virology 1993; 194: 263–276.MEDLINE 21 Pult I, Chouard T, Wieland S, Klemenz R, Yaniv M, Blum HE. A hepatitis B virus mutant with a new hepatocyte nuclear factor 1 binding site emerging in transplant-transmitted fulminant hepatitis B. Hepatology 1997; 25: 1507–1515.MEDLINE 22 Okamoto H, Yotsumoto S, Akahane Y, Yamanaka T, Miyazaki Y, Sugai Y, Tsuda F, et al. Hepatitis B viruses with precore region defects prevail in persistently infected hosts along with seroconversion to the antibody against e antigen. J Virol 1990; 64: 1298–1303.MEDLINE 23 Liang TJ, Hasegawa K, Munoz SJ, Shapiro CN, Yoffe B, McMahon BJ, Feng C, et al. Hepatitis B virus precore mutation and fulminant hepatitis in the United States. A polymerase chain reaction-based assay for the detection of specific mutation. J Clin Invest 1994; 93: 550–555.MEDLINE 24 Naoumov NV, Schneider R, Grotzinger T, Jung MC, Miska S, Pape GR, Will H. Precore mutant hepatitis B virus infection and liver disease. Gastroenterology 1992; 102: 538–543.MEDLINE 25 Pollicino T, Zanetti AR, Cacciola I, Petit MA, Smedile A, Campo S, Sagliocca L, et al. Pre-S2 defective hepatitis B virus infection in patients with fulminant hepatitis. Hepatology 1997; 26: 495–499.MEDLINE 26 Carman WF, Korula J, Wallace L, MacPhee R, Mimms L, Decker R. Fulminant reactivation of hepatitis B due to envelope protein mutant that escaped detection by monoclonal HBsAg ELISA. Lancet 1995; 345: 1406–1407.MEDLINE 27 Ghany MG, Ayola B, Villamil FG, Gish RG, Rojter S, Vierling JM, Lok AS. Hepatitis B virus S mutants in liver transplant recipients who were reinfected despite hepatitis B immune globulin prophylaxis. Hepatology 1998; 27: 213–222.MEDLINE 28 Protzer-Knolle U, Naumann U, Bartenschlager R, Berg T, Hopf U, Meyer zum Buschenfelde KH, Neuhaus P, et al. Hepatitis B virus with antigenically altered hepatitis B surface antigen is selected by high-dose hepatitis B immune globulin after liver transplantation. Hepatology 1998; 27: 254–263.MEDLINE 29 Stuyver LJ, Locarnini SA, Lok A, Richman DD, Carman WF, Dienstag JL, Schinazi RF. Nomenclature for antiviral-resistant human hepatitis B virus mutations in the polymerase region. Hepatology 2001; 33: 751–757.MEDLINE 30 Bock CT, Torresi J, Tillman HL, Locarnini SA, Manns MP. Replication fitness of hepatitis B virus polymerase mutants after antiviral treatment following liver transplantation [Abstract]. Hepatology 1999; 30: 299A. 31 Peters MG, Singer G, Howard T, Jacobsmeyer S, Xiong X, Gibbs CS, Lamy P, Murray A. Fulminant hepatic failure resulting from lamivudine-resistant hepatitis B virus in a renal transplant recipient: durable response after orthotopic liver transplantation on adefovir dipivoxil and hepatitis B immune globulin. Transplantation 1999; 68: 1912–1914.MEDLINE 32 De Man RA, Bartholomeusz A, Niesters HGM, Zondervan PE, Locarnini S. The sequential occurrence of viral mutations in a liver transplant recipient re-infected with hepatitis B virus: hepatitis B immune globulin escape, famciclovir non-response, followed by lamivudine resistance resulting in graft loss. J Hepatol 1998; 29: 669–675.MEDLINE 33 Sterneck M, Gunther S, Santantonio T, Fischer L, Broelsch CE, Greten H, Will H. Hepatitis B virus genomes of patients with fulminant hepatitis do not share a specific mutation. Hepatology 1996; 24: 300–306.MEDLINE 34 Buckwold VE, Xu Z, Chen M, Yen TS, Ou JH. Effects of a naturally occurring mutation in the hepatitis B virus basal core promoter on precore gene expression and viral replication. J Virol 1996; 70: 5845–5851.MEDLINE 35 Baumert T, Rogers S, Hawegawa J, Liang T. Two core promoter mutations identified in a hepatitis B virus strain associated with fulminant hepatitis result in enhanced viral replication. J Clin Invest 1996; 98: 2268–2276.MEDLINE 36 Gunther S, Piwon N, Will H. Wild-type levels of pregenomic RNA and replication but reduced pre-C RNA and e-antigen synthesis of hepatitis B virus with C(1653) → T, A(1762) → T and G(1764) → A mutations in the core promoter. J Gen Virol 1998; 79: 375–380.MEDLINE 37 Kosalaraksa P, Kavlick MF, Maroun V, Le R, Mitsuya H. Comparative fitness of multi-dideoxynucleoside-resistant human immunodeficiency virus type 1 (HIV-1) in an in vitro competitive HIV-1 replication assay. J Virol 1999; 73: 5356–5363.MEDLINE 38 Imamichi T, Berg SC, Imamichi H, Lopez JC, Metcalf JA, Falloon J, Lane HC. Relative replication fitness of a high-level 3'-azido-3'-deoxythymidine-resistant variant of human immunodeficiency virus type 1 possessing an amino acid deletion at codon 67 and a novel substitution (Thr → Gly) at codon 69. J Virol 2000; 74: 10958–10964.MEDLINE 39 Delaney WEt, Isom HC. Hepatitis B virus replication in human HepG2 cells mediated by hepatitis B virus recombinant baculovirus. Hepatology 1998; 28: 1134–1146.MEDLINE 40 Delaney WI, Edwards R, Colledge D, Shaw T, Torresi J, Miller TG, Isom HC, et al. Cross-resistance testing of antihepadnaviral compounds using novel recombinant baculoviruses which encode drug-resistant strains of hepatitis B virus. Antimicrob Agents Chemother 2001; 45: 1705–1713.MEDLINE 41 Melegari M, Scaglioni P, Wands J. Hepatitis B virus mutants associated with 3TC and famciclovir administration are replication defective. Hepatology 1998; 27: 628–633.MEDLINE 42 Liaw Y-F, Chien R-N, Yeh C-T, Tsai S-L, Chu C-M. Acute exacerbation and hepatitis B virus clearance after emergence of YMDD motif mutation during lamivudine therapy. Hepatology 1999; 30: 567–572.MEDLINE 43 Walter E, Keist R, Niederost B, Pult I, Blum HE. Hepatitis B virus infection of tupaia hepatocytes in vitro and in vivo. Hepatology 1996; 24: 1–5.MEDLINE Citing Literature Volume34, Issue2August 2001Pages 432-435 ReferencesRelatedInformation
Referência(s)